Emerging imaging techniques such as artery calcium scoring, electron beam computed tomography (EBT), and contrast-enhanced MRI and ultrasound are driving the cardiovascular in vivo diagnostics market to stronger growth than in general radiology, according to research firm Kalorama Information.
In vivo cardiac testing will grow 70% over the next five years, according to a report released Tuesday by the New York City-based firm. Due in part to increased interest in early assessment of cardiovascular disease, Kalorama is projecting the number of cardiac in vivo tests performed to increase across the board, with 7 of 11 modalities experiencing double-digit growth. Kalorama expects EBT, for example, to increase at a 60% annual rate through 2005.
EBT, MRI, CT, ultrasound, stress ultrasound, and remote heart-rate monitors are expected to displace more expensive, invasive procedures such as nuclear stress tests, x-ray angiography, and nuclear perfusion tests, according to the firm. Electrocardiograms and Holter monitors, will retain their importance, however, as a first-pass screening tool for cardiovascular disease, according to the company.
By AuntMinnie.com staff writers
September 19, 2001
Copyright © 2001 AuntMinnie.com
